1,7-phenanthroline has been researched along with Adjuvant Arthritis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deai, K; Hata, T; Kosugi, Y; Kurimoto, T; Matsushita, M; Miyai, A; Nakagawa, T; Ohta, T; Tamai, I; Yamada, T; Yamamoto, Y | 1 |
1 other study(ies) available for 1,7-phenanthroline and Adjuvant Arthritis
| Article | Year |
|---|---|
JTP-117968, a novel selective glucocorticoid receptor modulator, exhibits significant anti-inflammatory effect while maintaining bone mineral density in mice.
Topics: Aminopyridines; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Bone Density; Female; Glucocorticoids; Humans; Inflammation Mediators; Intercellular Signaling Peptides and Proteins; Joints; Male; Mice, Inbred BALB C; Mice, Inbred DBA; Osteoblasts; Phenanthrolines; Receptors, Glucocorticoid; Tumor Necrosis Factor-alpha | 2021 |